Involvement of the Multidrug Resistance Protein 3 in Drug Sensitivity and Its Expression in Human Glioma
Authors:
Open Access
- 1 February 2001
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 92 (2) , 211-219
Abstract
The multidrug resistance protein (MRP) family belongs to the ATP‐binding cassette superfamily (ABC) of transporters, which are involved in ATP‐dependent transport of hydrophobic compounds. One of the MRP family,MRP1, is partially associated with the multidrug resistance phe‐notype in brain tumors. In this study, we asked whether another MRP family gene,MRP3, could affect drug sensitivity to anticancer agents in human glioma cell lines and clinical glioma specimens. We first produced two antisense transfectants by introduction of antisenseMRP3cDNA into the glioma cell line NHG2, which endogenously expressesMRP3.The twoMRP3antisense transfectants showed 2‐ to 5‐fold increases in drug sensitivity to etoposide and cisplatin compared with NHG2 cells, but their sensitivity to vincristine or nitrosourea was not changed. TwoMRP3cDNA sense transfectants of pig kidney cell lines showed 4‐ to 6‐fold drug resistance to etoposide, but only 1.4‐ to 1.5‐fold to cisplatin. We next compared the mRNA levels of four ABC transporters, multi‐drug resistance 1 (MDR1),MRP1, MRP2andMRP3in clinical samples, including 34 patients with gliomas, by quantitative RT‐PCR analysis. In some of the clinical samples, increased expression ofMRP1andMRP3was apparent in malignant gliomas.In situhybridization revealed that glioma cells were stained withMRP3probe. MRP3 may modulate drug sensitivity to certain anticancer agents in human gliomas.Keywords
This publication has 32 references indexed in Scilit:
- Characterization of the Transport Properties of Cloned Rat Multidrug Resistance-associated Protein 3 (MRP3)Journal of Biological Chemistry, 1999
- Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response.1999
- Genomic Structure of the Canalicular Multispecific Organic Anion–Transporter Gene (MRP2/cMOAT) and Mutations in the ATP-Binding–Cassette Region in Dubin-Johnson SyndromeThe American Journal of Human Genetics, 1999
- Isolation of a Novel Human Canalicular Multispecific Organic Anion Transporter, cMOAT2/MRP3, and Its Expression in Cisplatin-Resistant Cancer Cells with Decreased ATP-Dependent Drug TransportBiochemical and Biophysical Research Communications, 1998
- Mutations in the canilicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndromeHuman Molecular Genetics, 1998
- A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells.1997
- A novel method for real time quantitative RT-PCR.Genome Research, 1996
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells.1991
- Chemotherapy of nonirradiated malignant gliomas.Phase II: Study of the combination of methyl-CCNU, vincristine, and procarbazineCancer, 1979